Metabolic behavior and prognostic value of early and end of treatment 18F-FDG PET/CT in adult Burkitt’s lymphoma: the role of Deauville and IHP criteria

References

• Swerdlow SH, Campo E, Harris NL, et al. World Health Organization Classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
   Google Scholar
• Bishop PC, Rao VK, Wilson WH. Burkitt's lymphoma: molecular pathogenesis and treatment. Cancer Invest. 2000;18:574–583.
   PubMed Web of Science ®Google Scholar
• Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104:3009–3020.
   PubMed Web of Science ®Google Scholar
• Lacasce A, Howard O, Lib S, et al. Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Leuk Lymph. 2004;45:761–767.
   PubMed Web of Science ®Google Scholar
• Wästerlid T, Brown PN, Hagberg O, et al. Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. Ann Oncol. 2013;24:1879–1886.
   PubMed Web of Science ®Google Scholar
• Molyneux EM, Rochford R, Griffin B, et al. Burkitt's lymphoma. Lancet. 2012;379:1234–1244.
   PubMed Web of Science ®Google Scholar
• Sandlund JT. Burkitt lymphoma: staging and response evaluation. Br J Haematol. 2012;156:761–765.
   PubMed Web of Science ®Google Scholar
• Just PA, Fieschi C, Baillet G, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in AIDS-related Burkitt lymphoma. AIDS Patient Care STDS. 2008;22:695–700.
   PubMed Web of Science ®Google Scholar
• Zeng W, Lechowicz MJ, Winton E, et al. Spectrum of FDG PET/CT findings in Burkitt lymphoma. Clin Nucl Med. 2009;34:355–358.
   PubMed Web of Science ®Google Scholar
• Karantanis D, Durski JM, Lowe VJ, et al. 18F-FDG PET and PET/CT in Burkitt's lymphoma. Eur J Radiol. 2010;75:e68–e73.
   PubMed Web of Science ®Google Scholar
• Bailly C, Eugène T, Couec M-L, et al. Prognostic value and clinical impact of (18)FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy. Front Med. 2014;1:16–54.
   Google Scholar
• Carrillo-Cruz E, Marín-Oyaga VA, Rodríguez MS, et al. Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma. Eur J Haematol. 2015;94:23–30.
   PubMed Web of Science ®Google Scholar
• Wen WX, Huang JJ, Li WY, et al. Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma. Chin J Cancer. 2015;34:608–613.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. JCO. 1999;17:1244.
   PubMed Web of Science ®Google Scholar
• Juweid ME, Stroobants S, Hoekstra OS, et al. Imaging Subcommittee of International Harmonization Project in Lymphoma. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma. JCO. 2007;25:571–578.
   PubMed Web of Science ®Google Scholar
• Cheson BD. The International Harmonization Project for response criteria in lymphoma clinical trials. Hematol Oncol Clin N Am. 2007;21:841–854.
   PubMed Web of Science ®Google Scholar
• Baratto L, Davidzon GA, Moghbel M, et al. Comparison between different PET and CT-based imaging interpretation criteria at interim imaging in patients with diffuse large B-cell lymphoma. Clin Nucl Med. 2018;43:1–8.
   PubMed Web of Science ®Google Scholar
• Lombion N, Robin P, Tempescul A, et al. Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus Rituximab: comparison between Deauville 5-point scale and International Harmonization Project criteria. Q J Nucl Med Mol Imaging. 2016.
   PubMedGoogle Scholar
• Meignan M, Gallamini A, Haioun C, et al. Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8–9 April 2010. Leuk Lymph. 2010;51:2171–2180.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. JCO. 2014;32:3059–3068.
   PubMed Web of Science ®Google Scholar
• Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. JCO. 2014;32:3048–3058.
   PubMed Web of Science ®Google Scholar
• Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989;7:1630–1636.
   PubMed Web of Science ®Google Scholar
• Hoelzer D, Walewski J, Döhner H, et al. Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood. 2014;124:3870–3879.
   PubMed Web of Science ®Google Scholar
• Ferreri AJ, Bruno Ventre M, Donadoni G, et al. Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma. Br J Haematol. 2012;159:252–255.
   PubMed Web of Science ®Google Scholar
• Gallamini A, Fiore F, Sorasio R, et al. Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation. Leuk Lymph. 2009;50:1761–1764.
   PubMed Web of Science ®Google Scholar
• Weiler-Sagie M, Bushelev O, Epelbaum R, et al. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med. 2010;51:25–30.
   PubMed Web of Science ®Google Scholar
• Albano D, Bertoli M, Ferro P, et al. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience. Eur J Nucl Med Mol Imaging. 2017;44:589–597.
   PubMed Web of Science ®Google Scholar
• Albano D, Bosio G, Giubbini R, et al. 18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation. Leuk Lymph. 2017;58:2328–2334.
   PubMed Web of Science ®Google Scholar
• Fallanca F, Alongi P, Incerti E, et al. Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC). Eur J Nucl Med Mol Imaging. 2016;43:1837–1848.
   PubMed Web of Science ®Google Scholar
• Isik EG, Kuyumcu S, Kebudi R, et al. Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET/CT according to ΔSUVmax, Deauville 5-point scale and IHP criteria. Ann Nucl Med. 2017;31:660–668.
   PubMed Web of Science ®Google Scholar